Mandated Part D Rebates Would Not Lead To Higher Premiums, Cost Shifts, MedPAC Commissioner Argues
This article was originally published in The Pink Sheet Daily
Executive Summary
In an online Health Affairs article, MedPAC commissioner Jack Hoadley and co-author Richard Frank rebut arguments against mandatory rebates on Medicare Part D drugs.